Azmi Nabulsi - 31 May 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol
PHAT
Transactions as of
31 May 2024
Transactions value $
$0
Form type
4
Filing time
31 May 2024, 18:34:53 UTC
Previous filing
22 Jan 2024
Next filing
17 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stoock Award $0 +7.5K +3.1% $0.00 250K 31 May 2024 Direct F1
holding PHAT Common Stock 3.58K 31 May 2024 By 401(k)
holding PHAT Common Stock 786K 31 May 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.